Literature DB >> 6236854

Heterogeneity of cell-associated and secretory heparan sulphate proteoglycans produced by cultured human neuroblastoma cells.

I N Hampson, S Kumar, J T Gallagher.   

Abstract

Biosynthetically radiolabelled heparan sulphate proteoglycans have been isolated from the growth medium and the cell lysate of a human neuroblastoma cell line (CHP100). Chromatography on Sepharose CL-4B identified two heparan sulphate proteoglycans in the medium (Kav 0.220 and 0.389), whereas in the cell lysate the major proteoglycan species were more heterogenous and of a smaller overall molecular size (Kav 0.407) than the medium-derived counterparts. Chromatography on Sepharose CL-6B of free heparan sulphate glycosaminoglycan chains showed that the majority of cell-layer-derived material heparan sulphate 2, Kav = 0.509) was smaller than medium heparan sulphates (heparan sulphate 1 and heparan sulphate 2, Kav 0.230 and 0.317). Analysis of the patterns of polymer sulphation by nitrous acid treatment, gel chromatography and high-voltage electrophoresis established that in each heparan sulphate fraction there was on average 1.1 sulphate residues per disaccharide with an N:O sulphate ratio of 1.1. Heparan sulphate in the medium had a high proportion of di-O-sulphated disaccharides in regions of the chain with repeat disaccharide sequences of structure GlcA-GlcNSO3, whereas cell-associated material was enriched in di-O-sulphated tetrasaccharides of alternating sequences GlcA-GlcNAc-GlcA-GlcNSO3. The identification of several populations of heparan sulphate proteoglycans differing in molecular size and glycosaminoglycan fine structure may reflect the functional diversity of this family of macromolecules in the nervous system.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6236854     DOI: 10.1016/0304-4165(84)90081-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Sulfated proteoglycans synthesized by Neuro 2a neuroblastoma cells: comparison between cells with and without ganglioside-induced neurites.

Authors:  K Watanabe; A Oohira; R Katoh-Semba; T Totsuka; K Yoshida
Journal:  Neurochem Res       Date:  1989-08       Impact factor: 3.996

Review 2.  Structure and function of heparan sulphate proteoglycans.

Authors:  J T Gallagher; M Lyon; W P Steward
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

3.  Axonal transport of proteoglycans to the goldfish optic tectum.

Authors:  J A Ripellino; J S Elam
Journal:  Neurochem Res       Date:  1988-05       Impact factor: 3.996

4.  Subcellular localization of the sulphation reaction of heparan sulphate synthesis and transport of the proteoglycan to the cell surface in rat liver.

Authors:  J M Graham; D J Winterbourne
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

5.  Molecular organization of heparan sulphate from human skin fibroblasts.

Authors:  J E Turnbull; J T Gallagher
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

6.  Further characterization of axonally transported proteoglycans.

Authors:  J S Elam
Journal:  Neurochem Res       Date:  1995-02       Impact factor: 3.996

7.  Sulphated and undersulphated heparan sulphate proteoglycans in a Chinese hamster ovary cell mutant defective in N-sulphotransferase.

Authors:  K J Bame; L Zhang; G David; J D Esko
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

8.  Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families of N-sulphated polysaccharides.

Authors:  J T Gallagher; A Walker
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

9.  Immunological characterization of basement membrane types of heparan sulfate proteoglycan.

Authors:  M Dziadek; S Fujiwara; M Paulsson; R Timpl
Journal:  EMBO J       Date:  1985-04       Impact factor: 11.598

10.  MYCN-dependent expression of sulfatase-2 regulates neuroblastoma cell survival.

Authors:  Valeria Solari; Lucia Borriello; Gianluca Turcatel; Hiroyuki Shimada; Richard Sposto; G Esteban Fernandez; Shahab Asgharzadeh; Edwin A Yates; Jeremy E Turnbull; Yves A DeClerck
Journal:  Cancer Res       Date:  2014-08-27       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.